Overview

Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study will assess the pharmacokinetics and safety following single dose of valsartan in Japanese pediatric patients with hypertension, chronic kidney disease, or nephrotic syndrome.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Valsartan